Statistics from Altmetric.com
Ressler JM, Karasek M, Koch L, et al. Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany. J Immunother Cancer 2021;9:e001701. doi: 10.1136/jitc-2020-001701
This article has been corrected since it first published. The provenance and peer review statement has been added.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.